Abstract: The present disclosure relates to an apparatus for obtaining 3D information using a photodetector array. The apparatus for obtaining 3D information includes: a light source unit configured to generate an optical signal of a predetermined wavelength band; a light transmission optical lens unit provided on a path of the optical signal and configured to emit the optical signal output from the light source unit in parallel or at a predetermined angle; an optical scanning unit configured to scan the light output from the light transmission optical lens unit to a surface of an object to be measured; a light reception optical lens unit configured to collect the light reflected from the surface of the object; and a photodetection unit configured to convert collected optical signals into respective electrical signals by arraying one or more photodetectors such that light reception portions thereof are collected at a center.

Abstract: Novel electric battery systems are disclosed utilizing selected ionic liquids as electrolytes and selected metals and metal oxides as electrodes. The ionic liquids utilize a substituted imidazolium cation, which does not have the corrosive safety and environmental concerns associated with corrosive acid and alkali electrolytes.

Abstract: The present invention relates to compositions and fusion proteins containing comprising Mycobacterium sp. antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the diagnosis, treatment and/or prevention of tuberculosis infection.

Abstract: A method of decreasing the expression of LIM kinase 1 in a cancer cell comprising; providing an oligonucleotide consisting of the sequence of SEQ ID NO: 1; providing a cancer cell comprising an mRNA encoding LIM kinase 1; and introducing the oligonucleotide into the cancer cell, wherein the oligonucleotide decreases the expression of LIM kinase 1 in the cancer cell. The method also provides compositions of an antisense RNA LIM kinase 1 that can be administered to an individual for the purpose of inhibiting a protein kinase pathway and which further comprises methods for treating and monitoring the proliferation and metastasis of cancer cells. A kit may be used in the detection and treatment of cancer.

Abstract: Provided are an apparatus and method of transmitting and receiving associated broadcasting contents based on a heterogeneous network. The transmission system generates a basic contents stream for basic contents configuring the broadcasting contents to transmit the basic contents stream to a terminal through a broadcasting network, generates an additional contents stream for additional contents associated with the basic contents to transmit the additional contents stream to the terminal through a communication network, and further transmits at least one of associated playing information on the basic contents and associated playing information on the additional contents to the terminal, and the reception terminal receives the basic contents stream, the additional contents stream, and the associated playing information and synchronize the basic contents and the additional contents with each other to play them, thereby playing the broadcasting contents in real time.

Abstract: Methods and devices for modified coding of blocks of residuals in the case of transform skipping. To better align the data with assumptions upon which the entropy coding scheme is based, the block of residual data is permuted at the encoder prior to entropy coding. The block of reconstructed data is then inverse permuted at the decoder to recover the reconstructed block of residuals. The permutation may include 180 rotation of the block, which may be of particular benefit in the case of intra-coded residuals.

Abstract: The invention described herein pertains to anticancer therapeutic agents that exhibit preferential cytotoxicity to malignant cells that express a cancer specific isoform of proliferating cell nuclear antigen (caPCNA) compared to cytotoxicity to comparable non-malignant cells, pharmaceutical compositions comprising the agents, and their use in cancer therapy.

Abstract: Analysis of executable binary code is performed without detection by defensive elements embedded within the executable binary code or within a system in which the executable binary code is executing. An identified suspect executable file is disassembled. Statically and dynamically analysis is performed on binary code of the disassembled executable file. An anti-anti-debugging function is implemented by executing program call functions in a manner which avoids detection of a debugging program by the defensive elements embedded within the executable binary code of the anti-debugging function of the executable binary code, thereby avoiding detection by the source of the suspect executable file.

Abstract: Compressed Level-Ordered Edge Sequence (CLOES) encodings are described. These techniques enable more aggressive compression of a state-set representation.

Abstract: A writing circuit for a magnetoresistive memory cell is provided.

Abstract: A method of contrast-enhanced computed tomography (CT) imaging can include repeatedly scanning a target region at a frequency during a session, the frequency initially being a first rate. After detecting an increase of the attenuation of radiation by a contrast-enhanced first structure within a target region, the frequency can be increased to a second rate. After detecting a subsequent decrease in the attenuation, the frequency can be decreased to a third rate.

Abstract: In one aspect, an ankle foot orthosis generally comprises a leg member, a foot member, and a drive assembly. The leg member is configured to be releasably fastened to a leg of the wearer. The foot member is configured to be releasably fastened to a foot of a wearer, the foot member having anterior and posterior ends. The drive assembly includes a link member hingedly secured to the foot member at a hinge location adjacent to the posterior end of the foot member.

Abstract: A housing has a front surface and a back surface. A keyboard and a corresponding bottom surface move between a non-deployed configuration and a deployed configuration. A tray slides in and out of the housing along one or more slots that are formed internal to the housing. This tray can include an internal surface having a first side that contacts the keyboard and an opposing second side that contacts the aforementioned bottom surface when the latter components are non-deployed. When moving to the deployed configuration the keyboard and bottom surface first move substantially parallel to the housing and then move substantially perpendicular to the housing. Projections on these components can interact with corresponding tracks formed in the housing to direct at the least this perpendicular movement.

Abstract: Disclosed herein, in certain embodiments, is a method of depositing a polymer onto a surface. In some embodiments, the method comprises using a high electric field and a high frequency vibratory motion to deposit a polymer solution onto the surface. Disclosed herein, in certain embodiments, is a method of manufacturing an electrode or diode. In some embodiments, the method comprises using a high electric field and a high frequency vibratory motion to deposit a polymer onto a surface. Further disclosed herein, in certain instances, is an electrode manufactured by any method disclosed herein. Further disclosed herein, in certain instances, is a diode manufactured by any method disclosed herein.

Abstract: Provided are an oxide sintered body and a sputtering target that are ideal for the production of an oxide semiconductor film for a display device. The oxide sintered body and sputtering target that are provided have both high conductivity and high relative density, are capable of forming an oxide semiconductor film having a high carrier mobility, and in particular, have excellent direct-current discharge stability in that long-term, stable discharge is possible, even when used by the direct-current sputtering method. The oxide sintered body of the invention is an oxide sintered body obtained by mixing and sintering zinc oxide, tin oxide, and an oxide of at least one metal (M metal) selected from the group consisting of Al, Hf, Ni, Si, Ga, In, and Ta. When the in-plane specific resistance and the specific resistance in the direction of depth are approximated by Gaussian distribution, the distribution coefficient ? of the specific resistance is 0.02 or less.

Abstract: Systems and methods for improving ethanol yield are provided. A feedstock is ground suitably fine for use in fermentation. The feedstock may include corn or any other suitable material. In some cases, the feedstock undergoes a fractionation prior to grinding. The ground feedstock may be slurried with water and enzymes to facilitate conversion of the starch in the feedstock to sugars. The slurry may be about 35% solids. After being slurried, an ethanologen may be added. Additionally, the pH of the slurry may be adjusted to between 4.2 and 5.2 to facilitate the priming A primer is added to the slurry. The primer may include any weak acid, and in some embodiments includes acetic acid. Acetic acid, when used as a primer, may be added at a concentration of between 1200 and 3600 parts per million. The slurry is fermented to produce improved yields of ethanol.

Abstract: A collimator for a computed tomography imaging device can include first and second leaves positioned on opposing sides of a primary radiation delivery window. The first and second leaves can include first and second gratings having a plurality of attenuating members with a plurality of secondary radiation delivery windows extending between adjacent attenuating members.

Abstract: The present application relates to high flow rate isolated regional treatment of cancer and proliferative disorders and conditions. For example, provided are methods, systems and devices for treating a cancer in a region of a subject using high flow rate isolated infusion.

Abstract: This invention relates to novel aminoglycoside antibiotics, which have potent antimicrobial activity against bacteria, which induce infectious diseases, particularly MRSA, and has no significant nephrotoxicity, and process for producing them. More particularly, the present invention relates to compounds represented by formula (Ia) or their pharmacologically acceptable salts or solvates, or their diastereomer mixtures, antimicrobial agents comprising them, and a process for producing them.

Abstract: A new and distinct rabbiteye blueberry variety is described. The variety results from selection among a population of seedlings derived from the controlled crossing of the blueberry varieties ‘Maru’ (not patented) and ‘Briteblue’ (not patented). The fruit of this new variety has an attractive appearance characterised by outstanding fruit quality with a good bloom and little grittiness, and medium to late fruiting season. The new variety appears suitable for the medium to late fresh fruit market and has been named ‘Velluto Blue’.